A) Plasma concentration-time profiles of lenalidomide in 21 patients.
B) Correlation between the observed area under the concentration-time curve (AUC0–24) and the predicted AUC0–24 calculated with an equation involving concentration at 4 h (C4h) after lenalidomide administration.